ATRX and central nervous system cancer: These criteria, which set a stringent level (at least > 55% of tumor cells) for the definition of the 1p/19q codeletion by FISH, identified all IDH1/2 mutated and ATRX wild type gliomas that meet the 2016 WHO Criteria for OGs.